Juvederm Ultra 4 Lidocaine 1ml

Juvederm Ultra 4 Lidocaine 1ml is a premium, cross linked hyaluronic acid dermal filler developed by Allergan Aesthetics, engineered specifically for the correction of severe cutaneous depressions, deep wrinkles, and structural soft tissue volumisation. Utilizing proprietary Hylacross technology, this clinical grade injectable features a highly viscous, fully cohesive, and smooth gel matrix. This specialized structure allows the gel to deliver robust mechanical lifting power and significant structural projection within the deep dermis or subcutaneous layers while maintaining high resistance to metabolic degradation.

Formulated with integrated 0.3 percent lidocaine hydrochloride to optimize patient comfort and clinical workflow efficiency, Juvederm Ultra 4 is a powerful volumetric backbar solution. It is highly indicated for treating pronounced nasolabial folds, smoothing severe marionette lines, and executing deep soft tissue augmentation in the malar (cheek), chin, and mandibular (jawline) regions. The smooth, monophasic composition ensures a soft, natural feel post-injection and uniform tissue integration, delivering consistent aesthetic results that persist for up to 12 months.

Juvederm Ultra 4 Lidocaine provides aesthetic medical professionals with a highly predictable, evidence based clinical asset designed to reconstruct volume deficits, smooth deep skeletal folds, and restore strong youthful contours.

Key Benefits:

Hylacross Matrix Strength: High-viscosity monophasic cross linking yields a highly cohesive, robust gel that ensures excellent lifting capacity and long-term retention.
Deep Volumetric Augmentation: Engineered to deliver maximum mechanical support and soft tissue projection in structural facial vectors.
Integrated Local Anesthetic: Features 0.3 percent lidocaine hydrochloride to lower extrusion resistance and maximize intraoperative patient compliance.
Smooth Dermal Integration: The non-granular fluid structure spreads uniformly throughout the deep subcutaneous layers, minimizing the risk of late stage palpable nodules.
Exceptional Degradation Resistance: Advanced chemical cross linking ensures the structural gel resists early enzymatic clearance, maintaining volume for up to 12 months.

Product Specifications and Packaging:

Volume: 1 x 1ml sterile, prefilled glass syringe (Often supplied as part of a 2 x 1ml pack; listed price reflects single 1ml syringe allocation).
Concentration: 24 mg/ml cross linked sodium hyaluronate + 0.3 percent lidocaine hydrochloride.
Injection Depth: Deep dermis or subcutaneous tissue layers.
Package Components: 1 x 1ml prefilled syringe, 2 x sterile 27G 1/2 needles.
Classification: CE marked and FDA approved medical device intended for professional clinical use only.

Usage:

For professional use only. Must be administered via deep linear threading, fanning, or bolus techniques into the deep dermis or subcutaneous layers by qualified, trained medical practitioners utilizing strict sterile clinical protocols.